• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
Research on related companies


Related Content

View the latest research on other companies in the sector. 

FY 21 results: solid portfolio performance

Good cash earnings growth GBL posted FY 2021 cash earnings of EUR474m, up 8% thanks to a sharp increase in Sienna Capital interest income, well contained holding costs and good yield enhancement activity, while dividends received from participations were slightly up. Sienna Capital contribution was said to be likely to continue to increase in the coming years. NAV continues to show above average discount NAV at end of December stood at EUR144/s up 10% YOY and +3% vs. end of Q3 21, mostly driven by value uplift at private assets (now accounting for notably Webhelp, on the back of earnings growth and re-rating) and Sienna Capital (thanks to fund revaluation). This shows a 32% discount to NAV compared to 25% for the historical average. The direct impact from the current context was said to be limited owing to low exposure of portfolio companies to Russia / Ukraine. The group indicated that it should continue buying back and cancelling shares (one third of the EUR500m program was executed) as long as NAV discount stays elevated. Room for further capital deployment - TP adjusted to EUR103 We have left our cash earnings estimates unchanged. With LTV of 4.3% (down from 7.3% last year) and liquidity of EUR4.4bn, management indicated that current market conditions would create opportunities to further build up the portfolio on both private and listed assets. Our Spot NAV in figure 1 points to EUR137, showing 35% discount. We have revised our valuation (based on a return to the NAV discount its historical average of 25%) to take into account the recent correction in equity markets. We maintain our Outperform.

Groupe Bruxelles Lambert SA Groupe Bruxelles Lambert SA

  • 11 Mar 22
  • -
  • BNP Paribas Exane
Private assets becoming a meaningful driver

After having reshaped and diversified its listed investments, GBL has shifted the portfolio towards private assets (now c.25% of published NAV) creating potential for hidden value. There is also optionality in asset management, although the business is in its early stages. NAV discount stands 5 points above historical average. We keep our Outperform rating and adjust our TP to EUR107. Outperformance driven by a pickup in asset rotation Over the past 12 months GBL outperformed the market despite soft performance from the listed portfolio and a widening discount to NAV. This was thanks to a pick-up in asset sales and deployment towards private assets (now accounting for c.25% of published NAV) driving an uplift in the 9-month NAV bridge. Share of private assets set to grow The share of private assets is set to grow with management targeting 40% of NAV in the medium term. This should create good potential for hidden value, already evidenced through the company''s stakes in Webhelp and Canyon, which have significantly surpassed GBL''s expectations compared to when those assets were acquired. Optionality in alternative asset management The group recently made inroads in alternative asset management with three announced acquisitions that look promising in the medium to long term. We have nevertheless not ascribed any value to these, as they are in their very early stages. Valuation adjusted for listed assets - Outperform maintained We have adjusted our TP from EUR108 to EUR107 to account for a mark-down in the listed portfolio, though this is largely offset by an uplift in the unlisted assets. Our target price is based on a 25% discount to NAV, consistent with the historical average. With EUR4.6bn of firepower (gross cash and credit facilities), the group is in a good position to deploy more capital on private assets, thus creating more potential for hidden value. We maintain our Outperform rating.

Groupe Bruxelles Lambert SA Groupe Bruxelles Lambert SA

  • 10 Feb 22
  • -
  • BNP Paribas Exane
Steady NAV progression in Q2

NAV progression driven by private assets GBL posted a NAV of EUR143 at end Q2 21 up 12.5% YTD and up 9% vs. end of Q1 21 level. Most of the progression was driven by revaluation of non-listed assets notably WebHelp (customer care) and Canyon (bike designer) that saw their earnings and valuation multiples expand during the first half. Steady asset rotation During H1 21, GBL disposed of EUR2.37bn of assets (reduction in Holcim, Umicore and GEA stakes) and acquired EUR901m (Canyon, MOWI and increase in commitment at Sienna Capital). Private assets now account for c. 20% of group''s net asset value. Discount to NAV remains above historical average With our spot NAV of EUR144, GBL''s current share price points to a 32% discount to NAV compared to 25% for the historical average. While holding companies show a wider discount during market turmoil, they generally tend to return to their historical average once equity markets recover. This has yet to be the case for GBL despite the outperformance of its portfolio (NAV progression in Q2 was 600bps above Eurostoxx 50 performance). Room for re-rating - Outperform maintained We have cut our earnings estimates to factor in the impact on dividends received from portfolio rotation. The higher share of private assets should be a good reservoir for hidden value and with 2.3% loan to value (vs. 7% at end 2020), the group has significant room to continue deploying capital. We have lifted our valuation from EUR101 to EUR108 to reflect the increase in gross asset value. The TP is based on a return of the NAV discount to its historical average of 25%. We maintain our Outperform rating.

Groupe Bruxelles Lambert SA Groupe Bruxelles Lambert SA

  • 03 Aug 21
  • -
  • BNP Paribas Exane
Discount to NAV still in ''crisis'' mode

Cash earnings impacted by lower dividends GBL posted FY 2020 cash earnings of EUR440m, down 26% affected by a decline in dividends received from its participations (all except SGS had to reduce or halt dividend payments as a result of the Covid-19 crisis). This was partly offset by well-contained holding costs and good yield enhancement activity. Cash earnings are expected to grow again in 2021 as dividend payments in most of the group''s participations should resume. Exacerbated discount to NAV Spot NAV at end December stood at EUR127/s up 14% compared to end Q3 thanks to re-rating at virtually all listed participations and re-valuation of non-listed assets (Sienna Capital private equity funds and Web Help going from transaction price to DCF/peer multiples). This points to a 35% discount to NAV compared to 25% for the historical average. While holding companies show a wider discount during market turmoil, they generally tend to return to their historical average once equity markets recover. This has yet to be the case for GBL despite the outperformance of its portfolio (NAV progression in Q4 was 580bps above Eurostoxx 50 performance). Room for re-rating and capital redeployment - TP lifted to EUR101 We have cut our cash EPS estimates by 8% this year and 9% next year to factor in the impact on dividends received from portfolio rotation. With LTV of 7.3% at the end of 2020, GBL has room to continue deploying capital while management indicated that asset rotation should pick up in 2021. Our Spot NAV in Figure 1 points to EUR135, showing a 36% discount to yesterday''s closing price. We have lifted our valuation from EUR84 to EUR101 which is based on a return of the NAV discount to its historical average of 25%. We maintain our Outperform rating.

Groupe Bruxelles Lambert SA Groupe Bruxelles Lambert SA

  • 12 Mar 21
  • -
  • BNP Paribas Exane
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In